Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

We sat down with journalist Mary Elizabeth Williams, one of the first patients treated with combination immunotherapy, to discuss her experience as an IO patient and how to bridge communication gaps among patients, doctors, and researchers.
The Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute (the Institute) recently brought together experts from relevant healthcare sectors and Institute leadership for a one-day meeting focused on the application of telemedicine in oncology and, specifically, in delivery of immunotherapy for cancers. The Telemedicine Roundtable, held in December, is one piece of a larger ACCC educational …
Rockville, MD — The Association of Community Cancer Centers (ACCC) congratulates the entire oncology community on the achievement of the largest one-year drop in cancer mortality—the record decline in annual cancer deaths was measured from 2016 to 2017. The numbers were reported in the American Cancer Society’s yearly Cancer Statistics, 2020, report released January 8. The study authors attribute …
In preparation for the ACCC 46th Annual Meeting & Cancer Center Business Summit (AMCCBS) in Washington, D.C. on March 4-6, we are talking with several featured speakers about the topics they plan to address at the summit. Debra Patt, MD, MPH, MBA—a breast cancer specialist in Austin, Texas, whose research focuses on imaging informatics for breast cancer, clinical decision support systems, predictive …
cSCC flyer - The Angeles Clinic Advanced Cutaneous Squamous Cell Carcinoma: Immuno-Oncology and the Evolving Landscape of Multidisciplinary Care Participate in an informative discussion on the data regarding the epidemiology of cutaneous squamous cell carcinoma (cSCC) and come away with an understanding of the potential preventative strategies for skin cancer including cutaneous squamous …
cSCC flyer: NYU Langone High Risk Cutaneous Squamous Cell Carcinoma: Recognition and Management Join a best practices seminar to identify lesions suspicious for cutaneous squamous cell carcinoma (cSCC), better understand the clinical and histologic features of high risk cSCC, and learn about management options.  Seating is limited to the first 50 registrants. Speaker: Desiree …
This article explores Johns Hopkins University’s unique approach to recruiting specialists outside the field of oncology to participate in its virtual immune-related Toxicity Team. In 2015, when Jarushka Naidoo, MBBCh, began working at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, she joined one of the first institutions to use immunotherapies to treat intractable …
Virtual Toxicity Team Cleveland Clinic This article explores how Cleveland Clinic is taking a unique approach to recruiting specialists outside the field of oncology to participate in immunotherapy multi- specialty immune-related adverse events (irAE) tumor boards. According to Pauline Funchain, MD, the right champions are essential to attracting the interest of specialists in the …
This article explores how Jefferson Health is taking a unique approach to recruiting specialists outside the field of oncology to participate in an Immuno-oncology Working Group. At Jefferson Health, detecting, diagnosing, and monitoring the irAEs that immuno- therapy patients can manifest during treat- ment is a group effort in a virtual space. Rather than meeting in person at a desig- nated …
In preparation for the ACCC 46th Annual Meeting & Cancer Center Business Summit in Washington, D.C. on March 4-6, we are talking with several featured speakers about the topics they plan to address at the summit. Lori Marcus—the Direct-to-Patient Workstream Lead at the Kraft Precision Medicine Accelerator—and Anne Quinn Young, MPH—Chief Marketing and Development Officer at the Multiple Myeloma …
As more patients are treated with single and combination immunotherapies for cancer, early identification and management of immune-related adverse events (irAEs) is critical to achieving desired outcomes with these new drugs. ACCCBuzz recently talked with Matthew R. Zibelman, MD, for perspective on irAE management in patients treated with immune checkpoint inhibitor therapy. Dr. Zibelman is a genitourinary …
We talk to a medical oncologist in a rural Montana community about the realities of rural cancer care, the importance of community oncology, and how he navigates common barriers to quality care.
In preparation for the ACCC 46th Annual Meeting & Cancer Center Business Summit in Washington, D.C. on March 4-6, we are talking with several featured speakers about the topics they plan to address at the summit. Susan Dentzer—a health policy expert and Senior Policy Fellow at The Duke-Margolis Center for Health Policy—will speak about "Disruptive Innovations That Could Change the Delivery of Cancer …
OFFICERS President Ali McBride, PharmD, MS, BCOP The University of Arizona Cancer Center Tucson, Arizona President-Elect Randall A. Oyer, MD Ann B. Barshinger Cancer Institute Lancaster, Pennsylvania Treasurer David R. Penberthy, MD, MBA Southside Regional Medical Center Petersburg, Virginia Secretary Krista Nelson, MSW, …
ACCC’s Immuno-Oncology Institute has developed the Survivorship Care Plans for Patients Receiving Immunotherapy as a resource for cancer programs and practices. and describes processes for developing survivorship care plans (SCPs) for patients treated with immunotherapy, effective practices in SCP design, and considerations for SCP delivery for this patient population.
December 18, 2019
Join us for a Town Hall with ACCC's Financial Advocacy Network Advisory Committee Members. Hear from three ACCC Financial Advocacy Network Advisory Committee members on tips for a successful new year and and how to implement them to benefit your patients, your program, and your financial advocates. Panelists Nikki L. Barkett, RN, BSN, OCN, Oral Antineoplastics Nurse Navigator, University of Arizona …
Rockville, MD – To prepare the multidisciplinary cancer care team for the growing prevalence of cancer and comorbidities among our nation’s graying population, the Association of Community Cancer Centers (ACCC)—in collaboration with The Gerontological Society of America and the International Society of Geriatric Oncology—has developed new tools and resources, offering expert insights through its Multidisciplinary …
According to LGBT HealthLink, lesbian, gay, bisexual, and transgender people are at an elevated risk for several types of cancer, including lung, anal, breast, and prostate. In addition, LGBT cancer survivors are 60 percent less likely than others to self-report good health and twice as likely to smoke than are heterosexuals. The healthcare community is increasingly recognizing that the social and …
The Centers for Medicare & Medicaid Services (CMS) released the final Medicare payment rules for calendar year (CY) 2020 in tandem this year on Nov. 1, 2019. Subsequently, on Nov. 15, the agency finalized hospital price transparency proposals originally included in the proposed CY 2020 Outpatient Prospective Payment System (OPPS) with the release of the 2020 Price Transparency Requirements for …
Survivorship programs are a crucial element of comprehensive cancer care centers. Without them, patients who have finished treatment may have to face unexpected physical and psychological limitations without professional support. This series of posts on innovations in survivorship care features ACCC member institutions that have developed new, innovative programs to benefit the well-being of cancer …